Prescribing Information for Our HIV Medicines

Medicine	Generic Name	Product Information
Apretude	cabotegravir long-acting for PrEP	Prescribing Information, including BOXED WARNING Patient Information
Cabenuva	cabotegravir and rilpivirine	Prescribing Information Patient Information
Dovato	dolutegravir and lamivudine	Prescribing Information, including BOXED WARNING Patient Information
Juluca	dolutegravir and rilpivirine	Prescribing Information Patient Information
Rukobia	fostemsavir	Prescribing Information Patient Information
Tivicay / Tivicay PD	dolutegravir	Prescribing Information Patient Information
Triumeq / Triumeq PD	abacavir, dolutegravir and lamivudine	Prescribing Information, including BOXED WARNING Medication Guide
Vocabria	cabotegravir	Prescribing Information Patient Information

```

Connect with ViiV Medical Experts

Call 1-888-226-8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Find my ViiV MSL

Request a scientific discussion

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at https://gsk.public.reportum.com or 1-877-844-8872, or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.

This site is intended for US Healthcare Professionals Only. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

Trademarks are owned by or licensed to the ViiV Healthcare group of companies.

Medicine

Generic Name

Product Information

Connect with ViiV Medical Experts